Muhammad Shahzad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Shahzad has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Ali Hashim
Al‐Aleem Medical College, University of Health Sciences Lahore Pakistan
2 shared publicationsAli Hassan
Fauji Foundation Hospital Rawalpindi Pakistan
2 shared publicationsAmna Zaman Khan
Al‐Aleem Medical College, University of Health Sciences Lahore Pakistan
2 shared publicationsFarah Shahzad
Khyber Medical College Peshawar Pakistan
2 shared publications- Muhammad Abdullah Ali
Khyber Medical College Peshawar Pakistan
2 shared publications Muhammad Uzair Khan Niazi
Department of Anatomy Foundation University Medical College Islamabad Pakistan
2 shared publications
Latest Publications
- Open Access
Trends and Demographics of Liver Fibrosis and Cirrhosis‐Related Mortality Among Adults Living in the United States From 1999 to 2020: A CDC Wonder Analysis
Introduction: Liver cirrhosis, the fifth leading cause of adult mortality, involves progressive, irreversible liver fibrosis and loss of function. Its rising prevalence necessitates studying trends, identifying high‐risk groups, and enhancing preventive strategies. This study aims to assess temporal trends and demographic disparities in liver fibrosis and cirrhosis‐related mortality in the United States from 1999 to 2020. Methods: Death certificates from the CDC WONDER(Centers for Disease Control and Prevention Wide‐Ranging Online Data for Epidemiologic Research) database for 1999–2020 were analyzed for liver fibrosis and cirrhosis‐associated mortality in adults > 25 years. AAMRs per 100 000 were stratified by year, sex, race/ethnicity, and region. Joinpoint Regression (v5.3.0.0) calculated annual percent change (APC) and average APC (AAPC), identifying significant trends ( p < 0.05, two‐tailed t test). Results: From 1999 to 2020, 787 375 liver cirrhosis‐related deaths occurred in adults > 25. AAMR increased from 16.61 (1999) to 18.93 (2020). Men had a higher AAMR (21.51; 95% CI: 21.44 to 21.57) than women (11.73; 95% CI: 11.68 to 11.77). AAMRs were highest in Non‐Hispanic (NH) American Indian (26.42; 95% CI: 25.91 to 26.93) followed by Hispanics (24.93; 95% CI: 24.77 to 25.09), NH White (16.71; 95% CI: 16.67 to 16.75), NH Black (15.13; 95% CI: 15.02 to 15.24), and NH Asian/Pacific Islander (9.29; 95% CI: 9.15 to 9.42). By region, the South had the highest AAMR (18.87; 95% CI: 18.8 to 18.93), followed by the West (15.75; 95% CI: 15.67 to 15.82), Midwest (14.55; 95% CI: 14.47 to 14.62), and Northeast (14.17; 95% CI: 14.1 to 14.25). Micropolitan (Nonmetro) areas had the highest AAMR (17.62; 95% CI: 17.49 to 17.74), while Large Fringe Metro Areas had the lowest AAMR (14.2; 95% CI: 14.13 to 14.27). Texas reported the highest AAMR (25.7); Nebraska reported the lowest (9.4). Discussion: Liver cirrhosis‐related mortality has risen since 1999, especially among Hispanic adults, men, and those in Southern or nonmetropolitan regions. Targeted prevention is needed to reduce mortality in these high‐risk groups.
Open AccessTrends and Demographics of Liver Fibrosis and Cirrhosis‐Related Mortality Among Adults Living in the United States From 1999 to 2020: A CDC Wonder Analysis
Introduction: Liver cirrhosis, the fifth leading cause of adult mortality, involves progressive, irreversible liver fibrosis and loss of function. Its rising prevalence necessitates studying trends, identifying high‐risk groups, and enhancing preventive strategies. This study aims to assess temporal trends and demographic disparities in liver fibrosis and cirrhosis‐related mortality in the United States from 1999 to 2020. Methods: Death certificates from the CDC WONDER(Centers for Disease Control and Prevention Wide‐Ranging Online Data for Epidemiologic Research) database for 1999–2020 were analyzed for liver fibrosis and cirrhosis‐associated mortality in adults > 25 years. AAMRs per 100 000 were stratified by year, sex, race/ethnicity, and region. Joinpoint Regression (v5.3.0.0) calculated annual percent change (APC) and average APC (AAPC), identifying significant trends ( p < 0.05, two‐tailed t test). Results: From 1999 to 2020, 787 375 liver cirrhosis‐related deaths occurred in adults > 25. AAMR increased from 16.61 (1999) to 18.93 (2020). Men had a higher AAMR (21.51; 95% CI: 21.44 to 21.57) than women (11.73; 95% CI: 11.68 to 11.77). AAMRs were highest in Non‐Hispanic (NH) American Indian (26.42; 95% CI: 25.91 to 26.93) followed by Hispanics (24.93; 95% CI: 24.77 to 25.09), NH White (16.71; 95% CI: 16.67 to 16.75), NH Black (15.13; 95% CI: 15.02 to 15.24), and NH Asian/Pacific Islander (9.29; 95% CI: 9.15 to 9.42). By region, the South had the highest AAMR (18.87; 95% CI: 18.8 to 18.93), followed by the West (15.75; 95% CI: 15.67 to 15.82), Midwest (14.55; 95% CI: 14.47 to 14.62), and Northeast (14.17; 95% CI: 14.1 to 14.25). Micropolitan (Nonmetro) areas had the highest AAMR (17.62; 95% CI: 17.49 to 17.74), while Large Fringe Metro Areas had the lowest AAMR (14.2; 95% CI: 14.13 to 14.27). Texas reported the highest AAMR (25.7); Nebraska reported the lowest (9.4). Discussion: Liver cirrhosis‐related mortality has risen since 1999, especially among Hispanic adults, men, and those in Southern or nonmetropolitan regions. Targeted prevention is needed to reduce mortality in these high‐risk groups.
- Open Access
Trends and Demographics of Vascular Intestinal Diseases‐Related Mortality Among Adults Living in United States From 1999 to 2020; A CDC Wonder Analysis
Introduction: Vascular intestinal disorders (VID), including mesenteric ischemia, ischemic colitis, and intestinal angiodysplasia, have a global incidence of 8.11/100 000/year and a mortality of 1.26/100 000/year (15.5% death rate), rising from ~1% to ~3% in childhood to ~50% after 95 years. In the US, the incidence of acute vascular insufficiency of the intestine (AVII) is rising, warranting detailed trend analysis.Methods: CDC WONDER death certificates (1999–2020) for adults > 25 years were analyzed using ICD‐10 code N55. Age‐adjusted mortality rates (AAMRs) per 100 000 were stratified by year, sex, race/ethnicity, and region. Joinpoint Regression (v5.2.0) calculated annual percent changes (APCs); significance was defined as p < 0.05.Results: Overall AAMR declined from 9.35 (1999) to 5.81 (2020). Women had higher AAMRs (7.63; 95% CI: 7.6–7.66) than men (6.5; 95% CI: 6.49–6.56). By race/ethnicity, AAMRs were highest in NH American Indian (7.89; 95% CI: 7.57–8.21), NH Black (7.84; 95% CI: 7.75–7.9), NH White (7.25; 95% CI: 7.22–7.28), Hispanic (5.91; 95% CI: 5.83–6), and NH Asian (3.59; 95% CI: 3.5–3.68). Micropolitan areas had higher AAMRs (7.92) than metropolitan (6.99). Regional AAMRs were highest in the Midwest (7.7; 95% CI: 7.65–7.75), followed by South (7.17; 95% CI: 7.13–7.21), West (7.02; 95% CI: 6.96–7.07), and Northeast (6.85; 95% CI: 6.79–6.9). Kentucky had the highest state AAMR (9.67; 95% CI: 9.43–9.9), Hawaii the lowest (4.59; 95% CI: 4.31–4.87). Oklahoma, Rhode Island, Tennessee, West Virginia, and Wyoming ranked in the top 90th percentile.Conclusion: Despite an overall decline, VID mortality remains high among women, NH American Indians, rural areas, and the Midwest—underscoring the need for targeted interventions.
Open AccessTrends and Demographics of Vascular Intestinal Diseases‐Related Mortality Among Adults Living in United States From 1999 to 2020; A CDC Wonder Analysis
Introduction: Vascular intestinal disorders (VID), including mesenteric ischemia, ischemic colitis, and intestinal angiodysplasia, have a global incidence of 8.11/100 000/year and a mortality of 1.26/100 000/year (15.5% death rate), rising from ~1% to ~3% in childhood to ~50% after 95 years. In the US, the incidence of acute vascular insufficiency of the intestine (AVII) is rising, warranting detailed trend analysis.Methods: CDC WONDER death certificates (1999–2020) for adults > 25 years were analyzed using ICD‐10 code N55. Age‐adjusted mortality rates (AAMRs) per 100 000 were stratified by year, sex, race/ethnicity, and region. Joinpoint Regression (v5.2.0) calculated annual percent changes (APCs); significance was defined as p < 0.05.Results: Overall AAMR declined from 9.35 (1999) to 5.81 (2020). Women had higher AAMRs (7.63; 95% CI: 7.6–7.66) than men (6.5; 95% CI: 6.49–6.56). By race/ethnicity, AAMRs were highest in NH American Indian (7.89; 95% CI: 7.57–8.21), NH Black (7.84; 95% CI: 7.75–7.9), NH White (7.25; 95% CI: 7.22–7.28), Hispanic (5.91; 95% CI: 5.83–6), and NH Asian (3.59; 95% CI: 3.5–3.68). Micropolitan areas had higher AAMRs (7.92) than metropolitan (6.99). Regional AAMRs were highest in the Midwest (7.7; 95% CI: 7.65–7.75), followed by South (7.17; 95% CI: 7.13–7.21), West (7.02; 95% CI: 6.96–7.07), and Northeast (6.85; 95% CI: 6.79–6.9). Kentucky had the highest state AAMR (9.67; 95% CI: 9.43–9.9), Hawaii the lowest (4.59; 95% CI: 4.31–4.87). Oklahoma, Rhode Island, Tennessee, West Virginia, and Wyoming ranked in the top 90th percentile.Conclusion: Despite an overall decline, VID mortality remains high among women, NH American Indians, rural areas, and the Midwest—underscoring the need for targeted interventions.